Safety and efficacy of favipiravir for the management of COVID-19 patients: A preliminary randomized control trial

BACKGROUND: The novel coronavirus disease, commonly called COVID-19, has already killed millions of lives. Our study aimed to identify a safe and right drug for the management of such globally threatened COVID-19. METHODS: This preliminary double-blinded randomized controlled trial was done among 57...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, S.M. Abdur, Kabir, Ahmedul, Abdullah, A.B.M., Alam, Md Billal, Azad, Khan Abul Kalam, Miah, Md Titu, Mowla, Syed Ghulam Mogni, Deb, Sudip Ranjan, Amin, Mohammad Robed, Asaduzzaman, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:
Clinical Trails
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095067/
https://www.ncbi.nlm.nih.gov/pubmed/35578658
http://dx.doi.org/10.1016/j.clinpr.2022.100145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095067/
https://www.ncbi.nlm.nih.gov/pubmed/35578658
http://dx.doi.org/10.1016/j.clinpr.2022.100145

Ejemplares similares